Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

3.

Green tea polyphenols reverse cooperation between c-Rel and CK2 that induces the aryl hydrocarbon receptor, slug, and an invasive phenotype.

Belguise K, Guo S, Yang S, Rogers AE, Seldin DC, Sherr DH, Sonenshein GE.

Cancer Res. 2007 Dec 15;67(24):11742-50.

4.

Green tea polyphenol and epigallocatechin gallate induce apoptosis and inhibit invasion in human breast cancer cells.

Thangapazham RL, Passi N, Maheshwari RK.

Cancer Biol Ther. 2007 Dec;6(12):1938-43. Epub 2007 Sep 1.

PMID:
18059161
5.

The estrogen receptor α is the key regulator of the bifunctional role of FoxO3a transcription factor in breast cancer motility and invasiveness.

Sisci D, Maris P, Cesario MG, Anselmo W, Coroniti R, Trombino GE, Romeo F, Ferraro A, Lanzino M, Aquila S, Maggiolini M, Mauro L, Morelli C, Andò S.

Cell Cycle. 2013 Nov 1;12(21):3405-20. doi: 10.4161/cc.26421. Epub 2013 Sep 17.

7.
8.

Trastuzumab-resistant HER2-driven breast cancer cells are sensitive to epigallocatechin-3 gallate.

Eddy SF, Kane SE, Sonenshein GE.

Cancer Res. 2007 Oct 1;67(19):9018-23.

9.
10.

EGCG inhibits growth of human pancreatic tumors orthotopically implanted in Balb C nude mice through modulation of FKHRL1/FOXO3a and neuropilin.

Shankar S, Marsh L, Srivastava RK.

Mol Cell Biochem. 2013 Jan;372(1-2):83-94. doi: 10.1007/s11010-012-1448-y. Epub 2012 Sep 13.

11.
12.
13.

ERalpha signaling through slug regulates E-cadherin and EMT.

Ye Y, Xiao Y, Wang W, Yearsley K, Gao JX, Shetuni B, Barsky SH.

Oncogene. 2010 Mar 11;29(10):1451-62. doi: 10.1038/onc.2009.433. Epub 2010 Jan 18.

PMID:
20101232
14.

Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases.

Sah JF, Balasubramanian S, Eckert RL, Rorke EA.

J Biol Chem. 2004 Mar 26;279(13):12755-62. Epub 2003 Dec 29.

15.

Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.

Thangapazham RL, Singh AK, Sharma A, Warren J, Gaddipati JP, Maheshwari RK.

Cancer Lett. 2007 Jan 8;245(1-2):232-41. Epub 2006 Mar 6.

PMID:
16519995
16.
17.

Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.

Mineva ND, Paulson KE, Naber SP, Yee AS, Sonenshein GE.

PLoS One. 2013 Sep 11;8(9):e73464. doi: 10.1371/journal.pone.0073464. eCollection 2013.

18.

AKT3 regulates ErbB2, ErbB3 and estrogen receptor α expression and contributes to endocrine therapy resistance of ErbB2(+) breast tumor cells from Balb-neuT mice.

Grabinski N, Möllmann K, Milde-Langosch K, Müller V, Schumacher U, Brandt B, Pantel K, Jücker M.

Cell Signal. 2014 May;26(5):1021-9. doi: 10.1016/j.cellsig.2014.01.018. Epub 2014 Jan 24.

PMID:
24463007
19.
20.

Suppression of MyD88- and TRIF-dependent signaling pathways of Toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea.

Youn HS, Lee JY, Saitoh SI, Miyake K, Kang KW, Choi YJ, Hwang DH.

Biochem Pharmacol. 2006 Sep 28;72(7):850-9. Epub 2006 Aug 4.

PMID:
16890209

Supplemental Content

Support Center